<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font23 { font-size : 23; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font23">and </span>
   <span class="font16">with </span>
   <span class="font15">were </span>
   <span class="font14">&amp;gt;. </span>
   <span class="font14">for </span>
   <span class="font14">nylidrin </span>
   <span class="font14">was </span>
   <span class="font14">influenza </span>
   <span class="font13">(N.D.) </span>
   <span class="font13">viral </span>
   <span class="font13">virus </span>
   <span class="font12">that </span>
   <span class="font12">against </span>
   <span class="font12">cells </span>
   <span class="font12">{background </span>
   <span class="font12">antiviral </span>
   <span class="font12">from </span>
   <span class="font11">The </span>
   <span class="font11">using </span>
   <span class="font11">margin </span>
   <span class="font11">activity </span>
   <span class="font11">{border-style </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">(&amp;gt;.) </span>
   <span class="font11">(Figure </span>
   <span class="font11">[]. </span>
   <span class="font11">infection </span>
   <span class="font11">receptor </span>
   <span class="font11">three </span>
   <span class="font11">MDCK </span>
   <span class="font11">active </span>
   <span class="font11">concentration </span>
   <span class="font11">infected </span>
   <span class="font11">which </span>
   <span class="font11">(pH </span>
   <span class="font11">Figure </span>
   <span class="font11">fusion </span>
   <span class="font11">protein </span>
   <span class="font10">Influenza </span>
   <span class="font10">antibody </span>
   <span class="font10">chemical </span>
   <span class="font10">its </span>
   <span class="font10">not </span>
   <span class="font10">nylidrin, </span>
   <span class="font10">After </span>
   <span class="font10">compounds </span>
   <span class="font10">could </span>
   <span class="font10">had </span>
   <span class="font10">membrane </span>
   <span class="font10">presence </span>
   <span class="font10">(.) </span>
   <span class="font10">This </span>
   <span class="font10">are </span>
   <span class="font10">but </span>
   <span class="font10">compounds, </span>
   <span class="font10">electrostatic </span>
   <span class="font10">into </span>
   <span class="font10">mice </span>
   <span class="font10">Nylidrin </span>
   <span class="font10">additional </span>
   <span class="font10">analysis </span>
   <span class="font10">control </span>
   <span class="font10">incubated </span>
   <span class="font10">their </span>
   <span class="font10">(HN), </span>
   <span class="font10">Viral </span>
   <span class="font10">[,]. </span>
   <span class="font10">acidic </span>
   <span class="font10">agonist </span>
   <span class="font10">also </span>
   <span class="font10">cell </span>
   <span class="font10">days </span>
   <span class="font10">field </span>
   <span class="font10">formation </span>
   <span class="font10">ifenprodil </span>
   <span class="font10">nylidrin. </span>
   <span class="font10">performed </span>
   <span class="font10">px; </span>
   <span class="font10">strains </span>
   <span class="font10">they </span>
   <span class="font10">used </span>
   <span class="font10">viruses </span>
   <span class="font10">{font-family </span>
   <span class="font10">(&amp;gt;,) </span>
   <span class="font10">ADRB </span>
   <span class="font10">HA, </span>
   <span class="font10">HA-mediated </span>
   <span class="font10">basis </span>
   <span class="font10">clenbuterol </span>
   <span class="font10">during </span>
   <span class="font10">effective </span>
   <span class="font10">font-size </span>
   <span class="font10">medium </span>
   <span class="font10">oseltamivir </span>
   <span class="font10">pharmacophore </span>
   <span class="font10">proton </span>
   <span class="font10">these </span>
   <span class="font10">two </span>
   <span class="font10">under </span>
   <span class="font10">weight </span>
   <span class="font10">(cat </span>
   <span class="font10">A/HN </span>
   <span class="font10">DMSO </span>
   <span class="font10">absence </span>
   <span class="font10">assay </span>
   <span class="font10">compound </span>
   <span class="font10">day </span>
   <span class="font10">described </span>
   <span class="font10">double; </span>
   <span class="font10">drug </span>
   <span class="font10">function </span>
   <span class="font10">hemagglutinin </span>
   <span class="font10">hydrochloride </span>
   <span class="font10">ifenprodil, </span>
   <span class="font10">inhibitor </span>
   <span class="font10">min. </span>
   <span class="font10">no. </span>
   <span class="font10">nuclear </span>
   <span class="font10">one </span>
   <span class="font10">p.i. </span>
   <span class="font10">phenyl </span>
   <span class="font10">positive </span>
   <span class="font10">proteins </span>
   <span class="font10">resistance </span>
   <span class="font10">resulting </span>
   <span class="font10">revealed </span>
   <span class="font10">strains, </span>
   <span class="font10">this </span>
   <span class="font10">time </span>
   <span class="font10">viability </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">(&amp;gt;) </span>
   <span class="font10">(HN) </span>
   <span class="font10">(Table </span>
   <span class="font10">(≥%), </span>
   <span class="font10">-well </span>
   <span class="font10">Antiviral </span>
   <span class="font10">PR-infected </span>
   <span class="font10">Statistical </span>
   <span class="font10">USA). </span>
   <span class="font10">administered </span>
   <span class="font10">aminoethanol </span>
   <span class="font10">anti-HA </span>
   <span class="font10">assay. </span>
   <span class="font10">before </span>
   <span class="font10">between </span>
   <span class="font10">blocking </span>
   <span class="font10">body </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">clenbuterol, </span>
   <span class="font10">completely </span>
   <span class="font10">development </span>
   <span class="font10">dose </span>
   <span class="font10">eliprodil </span>
   <span class="font10">endosomal </span>
   <span class="font10">group </span>
   <span class="font10">have </span>
   <span class="font10">host </span>
   <span class="font10">human </span>
   <span class="font10">inactive </span>
   <span class="font10">incubation </span>
   <span class="font10">maPR </span>
   <span class="font10">mock-infected </span>
   <span class="font10">neutral </span>
   <span class="font10">only </span>
   <span class="font10">plates </span>
   <span class="font10">points </span>
   <span class="font10">previously </span>
   <span class="font10">results </span>
   <span class="font10">small </span>
   <span class="font10">solid; </span>
   <span class="font10">step </span>
   <span class="font10">supernatants </span>
   <span class="font10">survival </span>
   <span class="font10">targeting </span>
   <span class="font10">trypsin </span>
   <span class="font10">vRNPs </span>
   <span class="font10">virus. </span>
   <span class="font10">whether </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">β-Adrenergic </span>
   <span class="font10">(A) </span>
   <span class="font10">(B) </span>
   <span class="font10">(Supplementary </span>
   <span class="font10">(i.e., </span>
   <span class="font10">(μM) </span>
   <span class="font10">A/Brisbane// </span>
   <span class="font10">Assay </span>
   <span class="font10">B). </span>
   <span class="font10">For </span>
   <span class="font10">HK, </span>
   <span class="font10">Infect. </span>
   <span class="font10">Korea </span>
   <span class="font10">M.K.; </span>
   <span class="font10">MOI </span>
   <span class="font10">OSV-C </span>
   <span class="font10">PBS </span>
   <span class="font10">RNA </span>
   <span class="font10">Rab </span>
   <span class="font10">S). </span>
   <span class="font10">Sino </span>
   <span class="font10">These </span>
   <span class="font10">amantadine </span>
   <span class="font10">analogues </span>
   <span class="font10">analogues, </span>
   <span class="font10">anti-influenza </span>
   <span class="font10">antibodies </span>
   <span class="font10">blot </span>
   <span class="font10">bold </span>
   <span class="font10">canine </span>
   <span class="font10">cells, </span>
   <span class="font10">cells. </span>
   <span class="font10">cellular </span>
   <span class="font10">changes </span>
   <span class="font10">channel </span>
   <span class="font10">comparisons </span>
   <span class="font10">conformational </span>
   <span class="font10">courier; </span>
   <span class="font10">days. </span>
   <span class="font10">determined </span>
   <span class="font10">direct-acting </span>
   <span class="font10">effect </span>
   <span class="font10">em; </span>
   <span class="font10">entry </span>
   <span class="font10">fenoterol, </span>
   <span class="font10">followed </span>
   <span class="font10">following </span>
   <span class="font10">further </span>
   <span class="font10">improve </span>
   <span class="font10">infection. </span>
   <span class="font10">inhibited </span>
   <span class="font10">inhibitory </span>
   <span class="font10">kidney </span>
   <span class="font10">mean </span>
   <span class="font10">min </span>
   <span class="font10">min, </span>
   <span class="font10">model </span>
   <span class="font10">modifications </span>
   <span class="font10">molecular </span>
   <span class="font10">molecules </span>
   <span class="font10">mouse </span>
   <span class="font10">negative </span>
   <span class="font10">number </span>
   <span class="font10">oral </span>
   <span class="font10">plaque </span>
   <span class="font10">polymerase </span>
   <span class="font10">preincubated </span>
   <span class="font10">pt;} </span>
   <span class="font10">reduction </span>
   <span class="font10">same </span>
   <span class="font10">samples </span>
   <span class="font10">selected </span>
   <span class="font10">showed </span>
   <span class="font10">subtype </span>
   <span class="font10">suggest </span>
   <span class="font10">therapeutic </span>
   <span class="font10">treated </span>
   <span class="font10">two-tailed </span>
   <span class="font10">unpaired </span>
   <span class="font10">various </span>
   <span class="font10">virus, </span>
   <span class="font10">when </span>
   <span class="font10">β-adrenergic </span>
   <span class="font10">μM) </span>
  </p>
 </body>
</html>
